Lilly buys another pain biotech; FDA sets decision for once-weekly PrEP pill

June 16, 2026 10:22 AM EDT News Briefing Lil­ly buys an­oth­er pain biotech; FDA sets de­ci­sion for once-week­ly PrEP pill ENDPOINTS Plus, news about Mer­ck, Mul­ti­Va­lent Bio­ther­a­pies, Alvotech, en­Gene, Mirum, and Adap­tive Biotech­nolo­gies. 💸 Eli Lil­ly ac­quires an­oth­er pain biotech: The In­di­anapo­lis phar­ma gi­ant has made … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER